Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec + liraglutide + metformin in adults with type 2 diabetes qualifying for treatment intensification
2011-004665-32Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Insulin degludec + liraglutide + metformin with Placebo + liraglutide + metformin (2 arms). Primary endpoint: Change from baseline in HbA1c (%). Started Jun 2012; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-004665-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004665-32.